CN107987089B - A kind of extract, preparation method and medical usage rich in chromene lactone - Google Patents
A kind of extract, preparation method and medical usage rich in chromene lactone Download PDFInfo
- Publication number
- CN107987089B CN107987089B CN201711275329.9A CN201711275329A CN107987089B CN 107987089 B CN107987089 B CN 107987089B CN 201711275329 A CN201711275329 A CN 201711275329A CN 107987089 B CN107987089 B CN 107987089B
- Authority
- CN
- China
- Prior art keywords
- netvein
- extract
- root element
- filtrate
- goldenray root
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000000284 extract Substances 0.000 title claims abstract description 62
- -1 chromene lactone Chemical class 0.000 title claims abstract description 25
- 238000002360 preparation method Methods 0.000 title abstract description 18
- BBFQZRXNYIEMAW-UHFFFAOYSA-N aristolochic acid I Chemical compound C1=C([N+]([O-])=O)C2=C(C(O)=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-N 0.000 claims abstract description 49
- 239000003814 drug Substances 0.000 claims abstract description 30
- 239000011347 resin Substances 0.000 claims abstract description 15
- 229920005989 resin Polymers 0.000 claims abstract description 15
- 231100000417 nephrotoxicity Toxicity 0.000 claims abstract description 7
- 239000000706 filtrate Substances 0.000 claims description 32
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- 239000012043 crude product Substances 0.000 claims description 12
- IDGUHHHQCWSQLU-UHFFFAOYSA-N ethanol;hydrate Chemical compound O.CCO IDGUHHHQCWSQLU-UHFFFAOYSA-N 0.000 claims description 12
- 238000001914 filtration Methods 0.000 claims description 10
- 241001113317 Farfugium Species 0.000 claims description 8
- 235000019441 ethanol Nutrition 0.000 claims description 8
- 210000003462 vein Anatomy 0.000 claims description 8
- 239000013078 crystal Substances 0.000 claims description 6
- 238000002425 crystallisation Methods 0.000 claims description 6
- 230000008025 crystallization Effects 0.000 claims description 6
- 239000003480 eluent Substances 0.000 claims description 6
- 238000005374 membrane filtration Methods 0.000 claims description 6
- 238000002604 ultrasonography Methods 0.000 claims description 6
- 239000000047 product Substances 0.000 claims description 4
- 150000001875 compounds Chemical class 0.000 abstract description 10
- 239000000463 material Substances 0.000 abstract description 9
- 239000000178 monomer Substances 0.000 abstract description 9
- 238000000926 separation method Methods 0.000 abstract description 3
- 238000010898 silica gel chromatography Methods 0.000 abstract description 3
- 241000700159 Rattus Species 0.000 description 21
- 239000000243 solution Substances 0.000 description 15
- 210000004027 cell Anatomy 0.000 description 13
- 206010023421 Kidney fibrosis Diseases 0.000 description 9
- 230000006907 apoptotic process Effects 0.000 description 9
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 238000002474 experimental method Methods 0.000 description 6
- 230000014509 gene expression Effects 0.000 description 6
- 210000003734 kidney Anatomy 0.000 description 6
- 206010016654 Fibrosis Diseases 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 230000004761 fibrosis Effects 0.000 description 5
- 238000003304 gavage Methods 0.000 description 5
- 210000005084 renal tissue Anatomy 0.000 description 5
- 230000000694 effects Effects 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 3
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 239000012894 fetal calf serum Substances 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 201000002793 renal fibrosis Diseases 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 230000004083 survival effect Effects 0.000 description 3
- 241000046585 Aristolochia clematitis Species 0.000 description 2
- 241001369615 Aristolochia fangchi Species 0.000 description 2
- 241000758794 Asarum Species 0.000 description 2
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 244000292697 Polygonum aviculare Species 0.000 description 2
- 235000006386 Polygonum aviculare Nutrition 0.000 description 2
- 230000003042 antagnostic effect Effects 0.000 description 2
- 230000008485 antagonism Effects 0.000 description 2
- 238000003556 assay Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 239000008157 edible vegetable oil Substances 0.000 description 2
- 238000000684 flow cytometry Methods 0.000 description 2
- 238000004811 liquid chromatography Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000001575 pathological effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- 240000008027 Akebia quinata Species 0.000 description 1
- 235000007756 Akebia quinata Nutrition 0.000 description 1
- 102000004121 Annexin A5 Human genes 0.000 description 1
- 108090000672 Annexin A5 Proteins 0.000 description 1
- BBFQZRXNYIEMAW-UHFFFAOYSA-M Aristolochate I Natural products C1=C([N+]([O-])=O)C2=C(C([O-])=O)C=C3OCOC3=C2C2=C1C(OC)=CC=C2 BBFQZRXNYIEMAW-UHFFFAOYSA-M 0.000 description 1
- 208000004884 Balkan Nephropathy Diseases 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 102100031181 Glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 240000004980 Rheum officinale Species 0.000 description 1
- 235000008081 Rheum officinale Nutrition 0.000 description 1
- 244000303379 Styrax officinalis Species 0.000 description 1
- 235000001361 Styrax officinalis Nutrition 0.000 description 1
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 230000001464 adherent effect Effects 0.000 description 1
- 230000001640 apoptogenic effect Effects 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 238000010191 image analysis Methods 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000008629 longdanxiegan Substances 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000011617 nephropathy animal model Methods 0.000 description 1
- 230000004987 nonapoptotic effect Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000017854 proteolysis Effects 0.000 description 1
- 238000011552 rat model Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000004926 tubular epithelial cell Anatomy 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 239000012224 working solution Substances 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
- C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
- C07D493/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
- A61K31/366—Lactones having six-membered rings, e.g. delta-lactones
- A61K31/37—Coumarins, e.g. psoralen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (4)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711275329.9A CN107987089B (en) | 2017-12-06 | 2017-12-06 | A kind of extract, preparation method and medical usage rich in chromene lactone |
PCT/CN2018/084057 WO2019109576A1 (en) | 2017-12-05 | 2018-04-23 | Use of benzopyran compound |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201711275329.9A CN107987089B (en) | 2017-12-06 | 2017-12-06 | A kind of extract, preparation method and medical usage rich in chromene lactone |
Publications (2)
Publication Number | Publication Date |
---|---|
CN107987089A CN107987089A (en) | 2018-05-04 |
CN107987089B true CN107987089B (en) | 2018-09-04 |
Family
ID=62036401
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201711275329.9A Active CN107987089B (en) | 2017-12-05 | 2017-12-06 | A kind of extract, preparation method and medical usage rich in chromene lactone |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107987089B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109700843B (en) * | 2019-02-01 | 2021-08-06 | 云南省药物研究所 | Application of ligularia reticulata extract in preparation of medicine for preventing and treating gastric ulcer and chronic atrophic gastritis |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2019109576A1 (en) * | 2017-12-05 | 2019-06-13 | 赵腾骅 | Use of benzopyran compound |
CN111072619B (en) * | 2019-12-11 | 2022-11-15 | 云南中烟工业有限责任公司 | Compound with drug-resistant bacterium resisting effect and preparation method and application thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107890466A (en) * | 2017-12-05 | 2018-04-10 | 赵腾骅 | A kind of chromene lactone is used for the purposes that for aristolochic acid and the Chinese medicine containing aristolochic acid is attenuated |
-
2017
- 2017-12-06 CN CN201711275329.9A patent/CN107987089B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107890466A (en) * | 2017-12-05 | 2018-04-10 | 赵腾骅 | A kind of chromene lactone is used for the purposes that for aristolochic acid and the Chinese medicine containing aristolochic acid is attenuated |
Non-Patent Citations (3)
Title |
---|
岩天麻化学成分的研究(Ⅰ);赵树年,等;《中草药》;19821231;第13卷(第3期);第12页 * |
岩天麻化学成分的研究(Ⅱ);陈于澍,等;《中草药》;19851231;第16卷(第6期);第37-38页 * |
岩天麻化学成分的研究(Ⅱ);陈于澍,等;《云南大学学报》;19860630;第8卷(第2期);第203-204页 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109700843B (en) * | 2019-02-01 | 2021-08-06 | 云南省药物研究所 | Application of ligularia reticulata extract in preparation of medicine for preventing and treating gastric ulcer and chronic atrophic gastritis |
Also Published As
Publication number | Publication date |
---|---|
CN107987089A (en) | 2018-05-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10086032B2 (en) | Method for preparing a Camellia nitidissima Chi lipid-lowering and hypoglycemic agent | |
CN107987089B (en) | A kind of extract, preparation method and medical usage rich in chromene lactone | |
Kumari et al. | Anti-inflammatory activity of dried flower extracts of Aegle marmelos in Wistar rats | |
CN104721301B (en) | A kind of apple polyphenol ethanol extract and its preparation method and application | |
CN102258598B (en) | Medicine prepared by active part of pawpaw, its preparation method and its application | |
CN101791336B (en) | Extract from long pepper and preparation method and application thereof | |
JP5622222B2 (en) | Hypolipidemic composition and use thereof | |
CN102370635B (en) | Application and preparation method of novel nardosinone | |
WO2021179902A1 (en) | Use of corydalis saxicola and preparation thereof in preparation of drug for treating non-alcoholic fatty liver diseases | |
CN107890466B (en) | A kind of chromene lactone is used for as aristolochic acid and the purposes of the attenuation of the Chinese medicine containing aristolochic acid | |
KR101182199B1 (en) | Composition containing Salvia miltiorrhiza extract or Cryptotanshinone for prevention or treatment of stroke | |
CN105198943B (en) | A kind of entitled tea hill how glycosides A acylated flavonoids glucosides and its preparation method and application | |
CN107951880B (en) | A kind of benzopyrone is used for as aristolochic acid and the purposes of the attenuation of the Chinese medicine containing aristolochic acid | |
CN105230836B (en) | A kind of health tea that rhinitis is had auxiliary therapeutic action and preparation method and detection method | |
CN101712670A (en) | Preparation method and application of 3'8''-bis-apigenin type bis-flavonoid | |
CN104224952A (en) | Preparation method for total anthraquinones of rheum officinale with stable and uniform proportions of all components | |
CN107028965A (en) | Application and product of the yuenkanin or derivatives thereof in fat-reducing medicament is prepared | |
CN107334793A (en) | The purposes of wintersweet platymiscium helicobacter pylori resistant | |
CN103760271B (en) | The detection method of brain heart clearing capsule | |
CN106109862A (en) | A kind of Rhizoma Paridis extract treating viral influenza | |
CN100464760C (en) | Use of cocklebur fruit total glucoside extract in preparing anti inflammation reaction product | |
CN103393708B (en) | Ginsenoside-ophiopogonin D composition for treating cardiovascular and cerebrovascular diseases | |
CN102670956A (en) | Application of Chinese medicinal composition to preparation of anti-myocardial cell apoptosis and/or anti-myocardial cell apoptosis related disease drug | |
CN105884841B (en) | A kind of preparation method of phenylpropanoids | |
CN105663150B (en) | A kind of application of phenylpropanoids and its pharmaceutically acceptable salt in the drug for preparing treatment diseases associated with inflammation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
TA01 | Transfer of patent application right | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20180802 Address after: 210012 21 flower god Avenue, Yuhuatai District, Nanjing, Jiangsu Applicant after: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Address before: 210009 China Medicine University, 639 Jiangning dragon road, Jiangning, Nanjing. Applicant before: Zhao Tenghua |
|
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extract enriched in benzopyran lactone as well as preparation method and medical application of extract Effective date of registration: 20190805 Granted publication date: 20180904 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2019320000006 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20200615 Granted publication date: 20180904 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2019320000006 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Extract enriched in benzopyran lactone as well as preparation method and medical application of extract Effective date of registration: 20200616 Granted publication date: 20180904 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980003127 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20210617 Granted publication date: 20180904 Pledgee: Bank of Jiangsu Limited by Share Ltd. Taishan Nanjing road subbranch Pledgor: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. Registration number: Y2020980003127 |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20231017 Address after: Rooms 1503 and 1504, 15th floor, Building F, Life Science Park, No. 22 Tiansheng Road, Jiangbei New District, Nanjing, Jiangsu Province, 210000 Patentee after: Nanjing Dao'er Medical Research Institute Co.,Ltd. Address before: 210012 21 flower god Avenue, Yuhuatai District, Nanjing, Jiangsu Patentee before: NANJING DARRA PHARMACEUTICAL TECHNOLOGY Co.,Ltd. |